Equity Research, Broker Reports, and media content on N4 Pharma Plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about N4 Pharma Plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard
N4
  • 15 Feb 24
In-vitro siRNA Update


Companies: N4 Pharma Plc

Turner Pope Investments
  • 18 Dec 23
Nuvec - oral delivery update


Companies: N4 Pharma Plc

Turner Pope Investments
  • 07 Dec 23
Cutting edge nanoparticle delivery system research

N4 Pharma has released an update on its ongoing in vitro double-loaded siRNA research work.

Companies: N4 Pharma Plc

Turner Pope Investments
  • 28 Jan 22
N4 Pharma makes good progress with Nuvec, a novel nanoparticle delivery system for vaccines and therapeutics
n4-pharma-makes-good-progress-with-nuvec-a-novel-nanoparticle-delivery-system-for-vaccines-and-therapeutics
  • 14 Sep 21
Hybridan Small Cap Feast 14-09-2021

Focusrite 1715p £1bn (TUNE.L) The global music and audio products company supplying hardware and software used by professional and amateur musicians and the entertainment industry, updated the market on a positive trading year in which revenue, profits and cash flow have all grown substantially. As a result of this strong trading performance during the year, the Group now expects revenue for the financial year ending 31 August 2021 to be ahead of market expectations at approximately £173m, up f

Companies: ALL PAT BHC TUNE MERC XTR N4P SBDS

Hybridan
  • 18 Aug 21
Small Cap Feast: 20/05/21

What’s cooking in the IPO kitchen? Oxford Cannabinoid Technologies Holdings Plc to IPO onto the Standard List. They are a pre-revenue pharmaceutical company with an objective to develop cannabinoid-based prescription medicines approved by regulatory agencies including the US Food and Drug Administration, the European Medicines Agency, and the Medicines and Products Healthcare Regulatory Authority. Their drug development strategy includes the development of proprietary cannabinoid derivatives, n

Companies: EUA ITX ADME CCS PURP N4P KAPE SBI NSCI

Hybridan
  • 15 Jul 21
SP Angel Healthcare Conditions- N4 Pharma (N4P.L): Update Note


Companies: N4 Pharma Plc

SP Angel
  • 24 Feb 21
SP Angel Healthcare Conditions

Novacyt S.A. (NCYT.L*): R&D Update | N4 Pharma (N4P.L): Full year results

Companies: Novacyt SAS (NCYT:LON)N4 Pharma Plc (N4P:LON)

SP Angel
  • 12 Feb 21
SP Angel Healthcare Conditions

N4 Pharma (N4P.L): Patent Update

Companies: N4 Pharma Plc

SP Angel
  • 09 Dec 20
SP Angel Healthcare Condition

N4 Pharma (N4P.L): Placing to raise £2m | e-therapeutics (ETX.L): COVID-19 project update (from yesterday)

Companies: e-Therapeutics plc (ETX:LON)N4 Pharma Plc (N4P:LON)

SP Angel
  • 03 Dec 20
SP Angel Healthcare Conditions

N4 Pharma (N4P.L): Formulation update | Beximco Pharma (BXP.L): Appointment of Non-Executive Directors | Tekcapital PLC (TEK.LN): Belluscura Files 510(k) for XPLO2R™ Portable Oxygen Concentrator

Companies: TEK N4P BXP

SP Angel
  • 18 Nov 20
SP Angel Healthcare Conditions- N4 Pharma (N4P.L): Initiation of Coverage


Companies: N4 Pharma Plc

SP Angel
  • 09 Nov 20
SP Angel Healthcare Conditions- 09-11-2020


Companies: N4 Pharma Plc (N4P:LON)IQ-AI Limited (IQAI:LON)

SP Angel
  • 05 Nov 20
SP Angel Healthcare Conditions- 05-11-2020


Companies: ValiRx PLC (VAL:LON)N4 Pharma Plc (N4P:LON)

SP Angel
  • 17 Sep 20
SP Angel Healthcare Conditions

Novacyt (NCYT.L): Interim results | N4 Pharma (N4P.L): Interim results

Companies: N4 Pharma Plc

SP Angel

N4 Pharma Plc

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on N4 Pharma Plc. We currently have 38 research reports from 5 professional analysts.

Latest News/RNS

(more news)
Date Source Announcement
18Apr24 07:00 RNS N4 Pharma PLC - Oral Delivery Update
04Mar24 15:13 RNS N4 Pharma PLC - Holding(s) in Company
29Feb24 07:00 RNS N4 Pharma PLC - Holding(s) in Company
15Feb24 07:00 RNS N4 Pharma PLC - in-vitro siRNA update
19Jan24 07:00 RNS N4 Pharma PLC - Patent Grant
18Jan24 10:15 RNS N4 Pharma PLC - Holding(s) in Company
16Jan24 07:00 RNS N4 Pharma PLC - Nanogenics Update
Get free RNS email alerts

  • Frequency of research reports

     

  • Research reports on

    N4 Pharma Plc

  • Providers covering

    N4 Pharma Plc

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing and novel high value drugs. The company trades under the ticker Lon:n4p